Xyzal 5mg & 0,5 mg/mL ORAL SOLUTION AND TABLETS
PDF Leaflet Revision Date: 30 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of symptoms associated with allergic conditions.
Dosage (summary)
Adults: 5 mg once daily. Adjust for renal impairment.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding.
Key Drug Interactions
- Alcohol
- Theophylline
- Ritonavir
Contraindications
- Hypersensitivity to levocetirizine
- End-stage renal disease
Common side effects
- Headache
- Somnolence
- Dry mouth
- Fatigue
Counselling Points
- Avoid alcohol
- May cause drowsiness
- Not for children under 2 years
Serious warnings
- Risk of urinary retention
- Risk of seizure aggravation
Important Disclaimer
The Xyzal 5mg & 0,5 mg/mL ORAL SOLUTION AND TABLETS professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
